I'm still wondering why Leo told you about the adaptive design in the B-OM trial, but not to others. I think it's significant and should be PR'ed. Any thoughts?

"We are doing an adaptive design trial. A Phase 2 that can turn into Phase 3."

http://investorshangout.com/post/view?id=2995833